Jaguar health ceo, board members, other c-suite members, and institutional and accredited investors invest in $3.448 million bridge financing priced at-the-market under nasdaq rules

San francisco, ca / access newswire / march 26, 2025 / jaguar health, inc. (nasdaq:jagx) ("jaguar" or "the company"), announced today that jaguar's president and chief executive officer lisa conte, three other members of the company's board of directors, and seven other c-suite and senior executives of jaguar along with selected institutional and accredited investors (each, an "investor") entered into securities purchase agreements, pursuant to which the company will issue up to $3.448 million aggregate principal amount of convertible promissory notes (collectively, the "notes") to such investors in a private placement priced at-the-market under nasdaq rules. the notes will have a 3-month maturity, will bear interest at 6% per annum, and will be convertible immediately at the option of the investors into shares of the company's common stock.
JAGX Ratings Summary
JAGX Quant Ranking